Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : ASN008
Therapeutic Area : Dermatology
Study Phase : Phase II
Sponsor : Sanofi
Deal Size : $372.0 million
Deal Type : Series D Financing
Formation Bio Raises Series D to Expand Drug Pipeline and AI-Driven Development Platform
Details : The fund aims to advance the pipeline, which includes the company lead product ASN008, a sodium channel blocker. Currently, it is being evaluated for the treatment of atopic dermatitis.
Brand Name : ASN008
Molecule Type : Small molecule
Upfront Cash : Undisclosed
June 26, 2024
Lead Product(s) : ASN008
Therapeutic Area : Dermatology
Highest Development Status : Phase II
Sponsor : Sanofi
Deal Size : $372.0 million
Deal Type : Series D Financing
LOOKING FOR A SUPPLIER?